Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease osteoporosis
Phenotype C0020437|hypercalcemia
Sentences 6
PubMedID- 22708102 Although there was severe osteoporosis with hypercalcemia in our patient, she remained asymptomatic.
PubMedID- 21887097 The use of bisphosphonates is indicated in osteoporosis, bony metastases with hypercalcemia, and paget’s disease due to their ability to inhibit osteoclastic activity and bone resorption.
PubMedID- 22147993 Therefore, bisphosphonates are being widely used in paget's disease, osteoporosis, malignancy with hypercalcemia, and osteolytic bone metastases (7, 10-13).
PubMedID- 25785219 There are reports in the literature of postpregnancy osteoporosis associated with hypercalcemia due to persistently elevated pthrp in a 31-year-old patient despite stopping nursing [8].
PubMedID- 21718535 Bisphosphonates have been widely used to treat hypercalcemia and ostealgia due to osteoporosis or osteitis deformans, and to treat malignant tumors that have metastasized to the bone [6].
PubMedID- 23825479 There are several case reports which indicate that excessive calcium intake or hormonal therapy for attenuation or prevention of osteoporosis can leads to hypercalcemia, which can cause various disorders by disruption of calcium homeostasis [28-31].

Page: 1